Temporary Disabled. :) please Go back Behind the news | Therapeutic Goods Administration (TGA) www.fgks.org » Address: [go: up one dir, main page] Include Form Remove Scripts Accept Cookies Show Images Show Referer Rotate13 Base64 Strip Meta Strip Title Session Cookies Contact TGA: info@tga.gov.au | 1800 020 653 | More contact info Translate | Subscribe Therapeutic Goods Administration (TGA) Australian Government Department of Health Main menu Home Safety informationReport a problem or side effectReporting adverse events involving medicines, vaccines or medical devices Report an issue with packaging or storage of a medicine AEMS guidance for health professionals AEMS guidance for sponsors Help us promote adverse event reporting: promotional resources kit AlertsCurrent year alerts All alerts RecallsAbout Australian recall actions Recall actions database Uniform recall procedure Prescription opioids Medicine shortages Early warning systemMonitoring communications About the Early Warning System Early Warning System: consumer questions and answers Early Warning System: health professional questions and answers Black Triangle SchemeBlack Triangle Scheme: Information for sponsors Safety information & educationMedicines safety Medical devices safety Database of Adverse Event Notifications (DAEN) COVID-19COVID-19 rapid antigen self-tests COVID-19 treatmentsCOVID-19 treatments: Provisional determinations Labels for COVID-19 treatments Therapeutic Goods (Poisons Standard) (COVID-19 Treatment - Roche) (Casirivimab and Imdevimab) Labelling Exemption 2021 COVID-19 treatments: Provisional registrations COVID-19 treatments: Treatments undergoing evaluation COVID-19 treatments: Advertising compliance COVID-19 treatments: Information for consumers and health professionals COVID-19 treatments: Information for sponsors (industry) COVID-19 vaccinesCOVID-19 vaccine approval process COVID-19 vaccines undergoing evaluation Provisional registrations COVID-19 vaccine safety monitoring and reporting News and updates COVID-19 vaccine advertising and import compliance Information for consumers and health professionals Information for sponsors (industry) International collaboration ConsumersReport a problem or side effectReporting adverse events involving medicines, vaccines or medical devices Travelling with medicines and medical devicesLeaving Australia Entering Australia Helpful links for travellers Buying medicines and medical devices onlineCounterfeit medicines and devices Can I import it?Personal importation scheme Medicinal cannabis: importation and the traveller's exemption MedicinesHow we regulate medicines Prescription medicines Complementary medicines Over-the-counter (OTC) medicines Vaccines What's on my medicine label? Accessing medicines during a medicines shortage What ingredients are in my medicine? Medical devicesMedical devices overview Transvaginal (urogynaecological) surgical mesh hub Breast implant hub Cosmetic injections Medical device cyber security Advertising hub Consumer information & educationSafety information for consumers Medicines & medical devices Community Q&A MedSearch | Medicine information search app Other web resources for consumers Medicinal cannabis products Health professionalsReport a problem or side effectReporting adverse events involving medicines, vaccines or medical devices Accessing unapproved productsSpecial access scheme Authorised prescribers Clinical trials Personal importation scheme Medicine shortages: Information for Health Professionals Accessing medicines during a medicine shortage Medicinal cannabis Nicotine vaping products Advertising MedicinesLabelling changes: information for health professionals Registration of medicines for the medical termination of early pregnancy Product Information Prescribing medicines in pregnancy database Medicine Shortages Information Initiative Fast track approval pathways for prescription medicines Medical devicesBreast implant associated-anaplastic large cell lymphoma (BIA-ALCL) Breast implant hub Changes to labelling and regulation of hard surface disinfectants (commencing 1 April 2019) Information for medical practitioners on pending up-classification of surgical mesh devices Patient information material for implantable medical devices Importing & supplying medical devices Advice about medical devices for health professionals BiologicalsRegulation of stem cell treatments: information for practitioners Safety informationMedicines Safety Update Medical Devices Safety Update Australian Adverse Drug Reactions Bulletin Medical device incident reporting & investigation scheme (IRIS) articles Implanting medical devices Other resources Health professional information & educationHealth professional educational materials IndustrySME AssistRegulation essentials Workshops and events Podcasts SME guidance material Educational videos Interactive decision tools Case studies Useful resources for business Understanding ingredient requirements Regulation basicsHow therapeutic goods are regulated in Australia Australian Register of Therapeutic Goods Industry educational materials Legislation & legislative instruments Advertising hub Labelling & packaging Ingredients in therapeutic goods Exporting therapeutic goods Importing therapeutic goods Clinical trials Cosmetics International scientific guidelines Safety information for industry Medicine shortages Advertising therapeutic goodsGetting started Complying with advertising requirements Learning resources Enforcement and outcomes News and reports Consultation and independent reviews Prescription medicinesAustralian Regulatory Guidelines for Prescription Medicines Prescription medicines regulation basics Standards and guidelines Forms for prescription medicine sponsors Regulatory decisions and notices Over-the-counter medicinesOTC medicines regulation basics Standards, guidelines and publications Forms for OTC medicine sponsors Regulatory decisions and notices Complementary medicinesComplementary medicine regulation basics Standards, guidelines and publications Forms for complementary medicine sponsors Complementary medicines reforms Regulatory decisions and notices SunscreensSunscreens regulation basics Standards, guidelines and publications Sunscreen reforms Medical devices & IVDsAustralian conformity assessment bodies Conformity assessment certificates, changes to requirements for certain medical devices Determinations for Australian conformity assessment bodies Face masks and COVID-19 Medical devices regulation basics Overview of medical devices and IVD regulation Unique Device Identification system IVD medical devices regulation basics Standards, guidelines and publications Forms for medical device & IVD sponsors Medical devices reforms Regulatory decisions and notices BiologicalsAustralian Regulatory Guidelines for Biologicals Regulatory framework for biologicals Biological standards Forms for the biologicals industry Regulatory decisions and notices Blood and blood componentsRegulation of blood Regulation of platelet-rich plasma (PRP), platelet-rich fibrin (PRF) and conditioned serum Forms for the blood and blood components industry Other therapeutic goodsDisinfectants, sterilants and sanitary products Tampons & menstrual cups Manufacturing therapeutic goodsManufacturing basics Manufacturing medicines Manufacturing medical devices & IVDs Manufacturing biologicals Manufacturing blood and blood components Manufacturing inspections Forms for manufacturers Notices for manufacturers Notices about GMP clearance Guidance on the management of GMP compliance signals Scheduling of medicines & poisonsScheduling basics Scheduling committees meeting dates and decisions timeframes The Poisons Standard (the SUSMP) Public notices about scheduling State/Territory scheduling information About the TGATGA basicsWho we are & what we do What the TGA doesn't do Structure TGA plans & reports TGA reforms Publications Forms Freedom of information Acronyms & glossary TGA Internet site Social media Contact the TGAHow can we help? TGA customer service standards Report a perceived breach or questionable practices Website feedback or error reporting Translate this website Educational materialsFor consumers For health professionals For industry For university students Education priorities 2018-19 Compliance and enforcement hubCompliance management Compliance actions and outcomes News and information Report a breach Regulatory decisions & noticesConsent to import, supply or export goods that do not comply with standards Cancellation requested by the sponsor - regulatory actions Failure to pay annual charges - regulatory actions TGA laboratory testing results AUST numbers on medicine labels S19A approval notices CommitteesTGA statutory advisory committees Other committees Employment & job vacanciesWorking for the TGA Recruitment information Living in Canberra Fees and paymentsSchedule of fees and charges Payment options Information & notices about TGA fees & payments Cost recovery implementation statements Forms (fees and payments) Annual Charge Exemption (ACE) scheme TGA Business ServicesTGA Business services: getting started with the TGA TGA Business services - how to use the site TGA Business Services forms InternationalInternational activities International cooperation Use of international assessments TGA international engagement strategy Links to international agencies & organisations TGA Internet site archiveArchived behind the news articles Archived committee information Archived consultations & reviews Archived media releases Archived newsletters and articles Archived presentations Archived regulatory decisions & notices Archived TGA publications News roomNews & public noticesLatest news & updates Media releases & statements Behind the news Newsletters & articles Subscribe to updates TGA tenders TGA laboratory testing reports Consultations & reviewsOpen consultations & reviews Closed consultations & reviews About consultations Consultation forecast Medicines and Medical Devices Regulation Review Events, training & presentationsEvents & training Presentations BlogTGA topics Decrease the text size Increase the text size Print this page Share You are hereHome » News room » News & public notices Behind the news Related information Community Q&A Behind-the-news articles are published in response to issues that are of interest to the community at a point in time, for example, subjects that have been in the media. Please let us know if you would like an issue addressed by emailing info@tga.gov.au or calling 1800 020 653. 2021 2020 2019 2018 2017 2016 2021 Post-market review of ventilators, CPAP and BiPAP devices 11 October 2021 27 August 2021 Ventilator Expert Working Group meeting outcomes available. Share your views in the 2021 TGA stakeholder survey 19 August 2021 The TGA is inviting consumers, health professionals, industry and other stakeholders to share their views in our annual stakeholder survey by 27 August 2021. TGA reduces timeframe for publishing adverse event reports 19 August 2021 Changes enhance transparency Regulation of Personal Protective Equipment and COVID-19 18 August 2021 An overview of the regulation of Personal Protective Equipment (PPE) in Australia, including face masks, gowns and gloves Advertising nicotine vaping products 18 August 2021 The TGA has today published a revised TGA advertising permission allowing pharmacies and pharmacy marketing to groups to promote, through … TGA approves more flexible storage conditions for Pfizer-BioNTech COVID-19 vaccine 24 May 2021 Updated storage conditions for the Pfizer COVID-19 vaccine Reminder: supply and advertising controls on medicinal cannabis 3 May 2021 The TGA is reminding businesses involved with medicinal cannabis products of their regulatory obligations under the Therapeutic Goods Act 1989 TGA warns consumers about potential harm from unlawfully supplied medicinal cannabis 3 May 2021 The TGA is warning consumers about the risks of buying medicinal cannabis products online Approval of updated storage conditions for the Pfizer COVID-19 vaccine 8 April 2021 Updated storage conditions for the Pfizer COVID-19 vaccine Regulation of thermometers and other temperature measuring medical devices and products for COVID-19 12 March 2021 This guidance assists thermometer sponsors and manufacturers to meet their regulatory obligations Ventilators and other devices intended for respiratory support for COVID-19 31 January 2021 Therapeutic Goods (Medical Devices—Ventilators) (COVID-19 Emergency) Exemption 2020 has ceased as of 31 January 2021. Importing personal protective equipment into Australia during the COVID-19 pandemic 31 January 2021 Therapeutic Goods (Medical Devices - Face Masks and Other Articles) (COVID-19 Emergency) Exemption 2020 ceases on 31 January 2021. Expedited recall system for faulty or unauthorised COVID-19 devices 31 January 2021 Therapeutic Goods (Medical Devices—Ventilators) (COVID-19 Emergency) Exemption 2020 has ceased as of 31 January 2021. Emergency COVID-19 exemptions end for ventilators and personal protective equipment 29 January 2021 Two emergency exemptions that were made to facilitate the supply of ventilators and personal protective equipment in Australia during the COVID-19 emergency will cease on 31 January 2021 Reuse of face masks and gowns during the COVID-19 pandemic 28 January 2021 Updated to include new section on Reprocessing of PPE by Healthcare facilities 2020 Country of origin and medicine quality 25 June 2020 There is no requirement for a medicine to display the country of origin on the label. How to spot a dodgy health product ad 14 May 2020 Ads for health products are everywhere, but don't believe everything you read Influenza vaccines released for 2020 season 8 May 2020 Information updated Coronavirus (COVID-19): Information on medicines and medical devices 7 April 2020 The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page 2019 Beware the Barbie drug: the dangers of using melanotan 13 November 2019 The Therapeutic Goods Administration (TGA) urges consumers to steer clear of products containing 'melanotan' TGA strengthens regulation of stem cell treatments 9 July 2019 New regulations for stem cell treatments in Australia came into force on 1 July 2019 Understanding Australia's new opioid overdose rescue treatment 4 March 2019 Australian launch of a new product called Nyxoid nasal spray for opioid overdoses Australian company pays fine for illegal medicine exports 18 February 2019 On 14 December 2018, the TGA issued an infringement notice for export of unlawful medicines from Australia 2018 Answering your questions: How the TGA regulates medical devices in Australia 21 December 2018 An overview of medical devices regulation in Australia Be sun smart. Wear sunscreen. 3 December 2018 A summary of how the TGA regulates sunscreens and how to use sunscreen effectively Company will pay over $25,000 in fines for alleged importation of unapproved therapeutic goods 29 November 2018 Operation Antlia targeted the illegal use of therapeutic goods in the cosmetics industry Watched Vitamania? Here's how the TGA regulates vitamins in Australia 15 August 2018 Find out how the TGA regulates vitamins in Australia A reminder about the safe and correct use of condoms 6 August 2018 A reminder on the safe use of condoms, including making sure you’re aware of the expiry date Claims about hemp and CBD oils misleading consumers 15 May 2018 The TGA is aware of false and misleading claims by some companies supplying products containing cannabidiol Codeine information: Frequently asked questions 12 April 2018 To find out what to do if your pharmacy does not stock the codeine medicine your doctor has prescribed, see the codeine FAQs Proposal to change the current Good Manufacturing Practice (GMP) fees and charges 9 February 2018 TGA clarification on the recent article from Pharma in Focus Complementary medicines reforms - Permitted Indications, including traditional indications 9 February 2018 The proposed reforms are designed to give greater certainty and protection for consumers All TGA approvals for prescription medicines in 2017 met the statutory timeframe of 255 working days 9 February 2018 A recent media report suggesting that half of TGA approvals for prescription medicines in 2017 exceeded statutory timeframes is incorrect Nurse and midwife fact sheet: Talking to people about the changes in codeine access 23 January 2018 From 1 February 2018, medicines containing codeine will no longer be available without a prescription Codeine stock management for wholesalers, sponsors and retail pharmacies 2 January 2018 Codeine stock management for wholesalers, sponsors and retail pharmacies' factsheet update 2017 Codeine access for rural and remote Australians 17 August 2017 Your pharmacist or other health professionals will be able to provide advice on the most appropriate medicines for you Responding to Lateline - accessing medicinal cannabis products 17 August 2017 Response to Lateline story of 16 August 2017 Pharmacist fact sheet: Talking to your patients about the changes in codeine access 13 July 2017 From 1 February 2018, medicines containing codeine will no longer be available without a prescription Consumer fact sheet: Codeine-containing medicines: Harms and changes to patient access 10 April 2017 Fact sheet on changes to codeine access 2016 Correcting the record: Australian Financial Review story on medicinal cannabis 7 December 2016 Correcting the record on the 5 December 2016 Australian Financial Review story Cannabis re-scheduling proposal - questions and answers 20 January 2016 Questions and answers on the re-scheduling proposal for cannabis The Therapeutic Goods Administration is part of the Health Products Regulation Group
Behind-the-news articles are published in response to issues that are of interest to the community at a point in time, for example, subjects that have been in the media.
Please let us know if you would like an issue addressed by emailing info@tga.gov.au or calling 1800 020 653.
The Therapeutic Goods Administration is part of the Health Products Regulation Group